News

Sophie Cunningham Becomes New Ambassador for SHARx Advocacy

Sophie Cunningham Becomes New Ambassador for SHARx Advocacy

Sophie Cunningham Joins SHARx as Brand Ambassador

SHARx, a leading patient prescription advocacy company, enthusiastically announces the addition of WNBA star Sophie Cunningham to its national brand ambassador team. Marking a significant step in its mission, SHARx aims to highlight the pressing issues surrounding the accessibility of high-cost medications that burden many individuals across the nation.

Empowering the Rising Tide Army

Cunningham joins a growing alliance of ambassadors within the SHARx Rising Tide Army (RTA), a movement dedicated to raising awareness about the staggering costs of prescription drugs. SHARx's commitment to this cause resonates deeply, and Cunningham's involvement brings a new voice to this vital advocacy effort. Other dedicated ambassadors include notable figures from various fields, such as:

  • Heath Shuler, three-term Member of Congress and former first-round draft pick of the Washington Commanders.
  • Brock Osweiler, a standout from the 2016 Super Bowl champion Denver Broncos.
  • Steve Jones, a celebrated 1996 U.S. Open Champion.
  • Gary Hallberg, an accomplished professional golfer with eleven titles worldwide.

Cunningham's Message of Accessibility

In reflecting on her new role, Cunningham expressed concern over the challenges many face in accessing lifesaving medications due to high costs. "There are so many people who can't access lifesaving medication because of cost, and it's wrong," she stated. "SHARx is committed to changing that, and I am proud to use my platform to amplify their mission." Her passionate commitment amplifies the collective goal of SHARx, which focuses on breaking down barriers to medication access.

SHARx's Vision for Healthcare

Since its inception in 2017, SHARx has worked tirelessly to remove hindrances to prescription drug access through innovative supply chain management and education initiatives. Corey Durbin, the Chief Executive Officer of SHARx, emphasizes that patients remain the key stakeholders within the complex U.S. pharmaceutical landscape. "Our members are the patients who are at risk of getting lost in the complexities of the U.S. pharma system," Durbin remarked. With influencers like Cunningham, SHARx aims to raise awareness and advocate for change.

Pushing for Change Against High Drug Costs

According to research, American consumers often pay exorbitantly high prices for brand-name medications, with costs reported to be up to 422% more than consumers internationally. Paul Pruitt, Chief Growth Officer of SHARx, personally understands these challenges as two of his sons require medications costing over $2 million annually. He passionately advocates for lower drug prices and better access for all American consumers.

The Impact of Unaffordable Medications

Pruitt pointedly noted the struggles countless Americans face due to the high costs of medications, stating, "Being without coverage for medications should not force the consumer into a situation where they have to choose between medications and groceries." This crisis necessitates an urgent response, as many individuals are grappled with the financial burden of pharmaceuticals.

Championing Affordable Choices

SHARx’s foundation rests on enabling consumers to have access to affordable medication options, emphasizing the importance of well-informed consumer choices. "We built SHARx to provide more people with the power to make their own drug procurement choices, both domestically and internationally," Durbin explained. The partnership with Cunningham promises to champion the cause further, helping to spread awareness and provide hope to those in need.

About Sophie Cunningham

Sophie Cunningham is not only recognized for her impressive athletic achievements at the University of Missouri but also for her exceptional career in the WNBA. Holding multiple accolades, she was the third overall pick by the Phoenix Mercury in the 2019 draft. Cunningham's presence in media, including her podcast Show Me Something, showcases her engaging personality and commitment to addressing pressing societal issues.

About SHARx

Founded to combat the high prices of prescription drugs, SHARx implements ethical sourcing strategies to ensure that all individuals receive essential medications without hidden markups or unnecessary expenses. Their commitment to transparency and affordability continues to gain attention, driven by passionate leaders who prioritize the well-being of their members.

Frequently Asked Questions

What role does Sophie Cunningham play at SHARx?

Sophie Cunningham serves as a brand ambassador, advocating for affordable access to prescription medications.

Why is the Rising Tide Army important?

The Rising Tide Army is crucial for raising awareness about the challenges posed by high-cost medications and engaging communities in advocacy efforts.

How does SHARx help consumers access medications?

SHARx provides innovative solutions in drug procurement, focusing on delivering affordable medication options to individuals while promoting transparency.

What are the impacts of high prescription costs on consumers?

High prescription costs lead many consumers to forgo necessary medications, impacting their health and financial stability.

Where can I learn more about SHARx?

More information about SHARx's mission and services can be found on their official website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Honeywell Aerospace Faces Class Action: Deadline Looms

Updated Category News Views 93

Navigating the Legal Storm with Honeywell Look, investors never have it easy, and when lawsuits start flying like today's news about Honeywell Aerospace, you better have your wits about you. Now here comes Kahn Swick & Foti, LLC, ringing the alarm bells. Any holders of Honeywell Aerospace stocks between late June and early September of '26 are squarely in the spotlight....

Continue Reading
Duolingo Faces Class Action: Deadline Looms for Plaintiffs

Updated Category News Views 208

Shaking up the education sector like a hot potato, investors have been thrown for a loop with Duolingo’s latest legal debacle. News broke that Kahn Swick & Foti, LLC, with significant backing from their heavyweight partner and former Louisiana Attorney General Charles C. Foti Jr., is spearheading a class action lawsuit against Duolingo, Inc. (NasdaqGS: DUOL). It’s one...

Continue Reading
Ensign Lawsuit Brews: Investor Stakes High by Dec. 7

Updated Category News Views 40

Ensign's Alleged Missteps Uncovered Man, grabbing headlines in the finance world often feels like catching a whirlwind, and yet, here we are with Ensign Group's latest debacle. This isn't some run-of-the-mill story we're sifting through. It's a class action lawsuit with teeth, aiming to rope in investors who played ball during a hefty stretch running from February 10,...

Continue Reading
Lunit, Summit Tackle Tumor Analysis with AI Platform

Updated Category News Views 212

Amid whispers of AI revolutionizing every industry, let's zero in on its latest pit stop—oncology R&D. Lunit, shaking hands with Summit Therapeutics, plans to bring artificial intelligence into the tumor microenvironment analysis game, thanks to the Lunit SCOPE IO platform. This isn't just another lab experiment; it's a step towards redefining how we understand cancer's...

Continue Reading
DigitalXForce Booms with 514% Growth and Major Backing

Updated Category News Views 228

Massive Growth and Strategic Investment in DigitalXForce Now here’s a company that’s shaking things up—DigitalXForce. Right on the back of a staggering 514% growth, they’ve corralled a strategic investment from Arsenal Growth Equity. If you blink, you might miss just how fast they’re sprinting through the tech landscape. Institutional Support Backing the...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 81

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 34

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
York Space Systems Class Action: Deadline Approaches

Updated Category News Views 121

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 74

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 150

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Fluor Corporation's Recent Class Action Developments

Updated Category News Views 255

Fluor Corporation: An Overview of Recent Developments Fluor Corporation is a global leader in providing engineering, procurement, and construction (EPC) services, along with project management support. The company is dedicated to delivering essential infrastructure and the latest technology solutions while enhancing its operational efficiencies. Class Period and...

Continue Reading
Securing Your Rights: A Call to Sarepta Therapeutics Investors

Updated Category News Views 150

Urgent Reminder for Sarepta Therapeutics Investors In light of recent legal developments, it's crucial for investors of Sarepta Therapeutics, Inc. to take action regarding their investments in this biopharmaceutical company. Investors who acquired securities of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) are being notified of upcoming legal deadlines that could impact their...

Continue Reading
GMT Pay Revolutionizes Everyday Spending with Web3 Earnings

Updated Category News Views 151

GMT Pay: A New Era in Payment Solutions Welcome to the exciting world of GMT Pay, the groundbreaking payment solution that allows users to turn their Web3 earnings into everyday purchases. This innovative platform is spearheaded by FSL, the development studio behind the renowned Web3 lifestyle app, STEPN. With GMT Pay, users can easily access their earnings from various...

Continue Reading
Trucept, Inc. Unveils 2022 Financial Results and Future Prospects

Updated Category News Views 40

Trucept, Inc. Announces Major Financial Developments Trucept Inc. DBA Afinida is excited to share its audited financial results for the year 2022. With a keen focus on delivering transparency, the company underscores its commitment to its shareholders and clients alike. CEO Norman Tipton expresses optimism about the upcoming 2023 financial report, which is expected to be...

Continue Reading
Bitcoin's Critical Support Level for Future Growth Explained

Updated Category News Views 174

Understanding Bitcoin's Correction Phase Bitcoin's (CRYPTO: BTC) ongoing correction phase has garnered much attention among traders and investors alike. Key Insights From Technical Analysis Technical analyst Kevin has pointed out that Bitcoin's correction patterns notably exhibit similarities across different market cycles. Historically, even amidst various macroeconomic...

Continue Reading